Fresh Tracks Therapeutics, Inc.（FRTX）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · FRTX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2023-12	2022-12	2021-12	2020-12	2019-12
Revenue
Revenue	$8.01M	$6.94M	$0.40M	$1.82M	$7.92M
Cost of Revenue	$0.00M	$14.04M	$28.23M	$11.22M	$20.21M
Gross Profit	$8.01M	($7.10M)	($27.83M)	($9.39M)	($12.30M)
Gross Margin %(computed)	100.00%	-102.26%	—	-515.59%	-155.32%
Operating Expenses
R&D Expenses	$3.18M	$14.04M	$28.23M	$11.22M	$20.21M
G&A Expenses	$11.18M	$14.43M	$12.42M	$11.58M	$12.17M
Total Operating Expenses	$14.37M	$28.48M	$40.65M	$22.80M	$32.38M
Operating Income	($6.36M)	($21.53M)	($40.24M)	($20.98M)	($24.47M)
Operating Margin %(computed)	-79.44%	-310.15%	—	—	-309.06%
Interest Income	$0.00M	$0.00M	$0.00M	$0.06M	$0.00M
Interest Expense	$0.01M	$0.01M	$0.07M	$0.00M	$2.10M
Income Before Tax	($5.69M)	($21.10M)	($39.47M)	($20.91M)	($23.88M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	($5.69M)	($20.66M)	($39.52M)	($20.90M)	($25.95M)
Net Margin %(computed)	-71.12%	-297.58%	—	—	-327.71%
Per Share & EBITDA
EPS (Basic)	$-0.96	$-7.36	$-22.14	$-38.37	$-386.21
Wtd Avg Shares	5.91M	2.81M	1.78M	0.54M	0.07M
EBITDA	($5.65M)	($21.06M)	($39.38M)	($20.90M)	($21.75M)
EBITDA Margin %(computed)	-70.55%	-303.37%	—	—	-274.76%